This company is included in Intelligence Lab

Tessera Therapeutics

Tessera Therapeutics logo

Website
https://tesseratherapeutics.com/
Founded
2018

Technologies

Gene Therapy Startups

Tessera Therapeutics is pioneering Gene Writing—a revolutionary genome engineering technology that is designed to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source

Tessera Therapeutics raised over $230 million in the Series B round from an impressive group of investors to accelerate the research and development of their technology platform

gene editing gene writing

Articles Mentioning This Company

7 Biotechs Fighting Rare Diseases With Gene-Editing Tech

     Articles
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases are defined as those affecting fewer than 1 in 200.000 people with almost 80% of all rare diseases being of genetic nature. With recent progress in gene-editing technologies, including breakthroughs …